Page 7 - DME Pharmacy, April 2019

MY
CY CMY K
“The focus has been to deliver solutions
that are faster, quieter, and easier to use for
the patient so that they have more time for life. Treating their respiratory disease does not have to stop a patient from doing what they love,” Trevenen says.
“Technology advancements such as miniatur- ization and the availability of electronic compo- nents have allowed for the evolution of the por- table nebulizer market. Advances in fabrication processes such as electroforming have enabled the development of new vibrating mesh tech- nology that is capable of producing droplets ≤3 microns of medication. Philips InnnoSpire Go portable mesh nebulizer uses this technology to deliver treatment in four minutes (2.5 ml Salbu- tamol). Not all meshes are fabricated from the same material, nor do they have the same de-
their inhaler.
INTEGRATING THE
RIGHT TECHNOLOGIES
Philips has offered respiratory equipment since the 1980s, and offers a range of newer products with high-tech features that aim to improve compliance through comfort and time saved.
sign specifications. Differences in material and design will affect performance and reliability.” Philips’ I-neb Adaptive Aerosol Delivery
(AAD) System is a metered dose system. It uses a sensor to monitor the patient’s breath-
ing pattern and adapt aerosol delivery during inhalation to deliver medications that require
a precision dose delivery. Because the drug
is only being delivered during inhalation, the technology minimizes drug waste compared to
Untitled-3
1
3/5/19 11:00 AM
April Issue DME Pharmacy Half Page Island.pdf
1 3/5/19
9:36 AM
regularly to achieve and maintain control of persistent asthma.”
At least for now, there really isn’t a role for DME pharmacies in PropellerHealth’s business model. The company works with clinical, PBM and pharma partners for referrals and to cover the cost of the devices and monitoring, a com- pany spokeswoman says. But DMEs are “a chan- nel we are definitely exploring,” she says. “We are especially interested in the new Medicare payment rule around reimbursement for remote patient monitoring, and whether this will expand to cover DME pharmacy partners.”
Meantime, patients enroll on Propeller via C
the company’s website, through both clinical M
referral and direct-to-patient programs. Patients
can sign up from home or in a doctor’s office. Once the patient enrolls in the program, they CM
can download the app and are sent a sensor for
Y
See us at Medtrade, Booth #415
hme-business.com
DME Pharmacy | April 2019 7
“Digital medicines provide patients with a
greater sense
of control over
their disease by placing the tools to self-manage in the palm of their hand. ”
— Chris Hogg, Propeller Health